We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avacta Group PLC 12 December 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Dose Escalation and Recommended Dose for Expansion (RDE) Arms of the AVA6000 Phase 1a...
Avacta Group PLC 30 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") R&D Spotlight focusing on pre|CISION® technology and pipeline advances LONDON - Oct...
Avacta Group PLC 28 October 2024 28 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Block Listing Six Monthly Return Avacta Group plc (AIM:...
Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona LONDON – Oct...
Avacta Group PLC 24 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular...
Avacta Group PLC 21 October 2024 Avacta Group plc ("Avacta" or the "Group" or the "Company") Issue of Equity and Total Voting Rights London - Oct. 21, 2024 - Avacta Therapeutics (AIM:...
Avacta Group PLC on Monday revealed it has agreed to collaborate with AI-focused precision medicine business, Tempus ...
Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology LONDON – Oct. 21, 2024 – Avacta...
Avacta Group PLC 21 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in...
Avacta Group PLC on Thursday revealed it has expanded its oncology pipeline with two novel preclinical assets. AVA6 ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.25 | 9.82658959538 | 43.25 | 48.5 | 42.5 | 1035358 | 46.13246379 | DE |
4 | 1 | 2.15053763441 | 46.5 | 52.5 | 42.5 | 1372704 | 46.79847983 | DE |
12 | -2.5 | -5 | 50 | 70 | 42 | 1872184 | 51.35212561 | DE |
26 | 7.5 | 18.75 | 40 | 86 | 40 | 2147795 | 59.3590384 | DE |
52 | -71 | -59.9156118143 | 118.5 | 121 | 39.75 | 2279826 | 59.52185028 | DE |
156 | -61 | -56.2211981567 | 108.5 | 187.5 | 38.5 | 1936995 | 91.55624856 | DE |
260 | 30.75 | 183.582089552 | 16.75 | 290 | 13.5 | 2670748 | 115.42657245 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions